Irlab Therapeutics AB Announces CEO Changes
Medicine at Karolinska Institutet. Gunnar Olsson is also an honorary Doctor of Medicine at the University of Gothenburg. He has more than 30 years of experience in leading positions in the life science industry. He has been Vice President & Head of Cardiovascular and Gastrointestinal Therapy Areas in Global R&D at AstraZeneca and has served on several boards of biotech companies and the European Society of Cardiology. Details of current board assignments are available on the company's website.